An optimistic approach to nanotechnology in Alzheimer's disease management: An overview

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Journal of Drug Delivery Science and Technology

• Publication date

  2023-09-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.jddst.2023.104722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The application of nanotechnology in treatment of Alzheimer’s disease

  2022cited by this paper
• Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer’s Disease

  2022cited by this paper
• 2022 Alzheimer's disease facts and figures

  2022cited by this paper
• Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential

  2021cited by this paper
• Mechanisms Involved in Microglial-Interceded Alzheimer’s Disease and Nanocarrier-Based Treatment Approaches

  2021cited by this paper
• Biomarkers used in Alzheimer's Disease diagnosis, treatment, and prevention.

  2021cited by this paper
• Intranasal drug delivery for treatment of Alzheimer’s disease

  2021cited by this paper
• Nanomedicine: A Promising Way to Manage Alzheimer’s Disease

  2021cited by this paper
• Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice

  2020cited by this paper
• A facile biosensor for Aβ40O based on fluorescence quenching of prussian blue nanoparticles.

  2020cited by this paper
• RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer’s Disease

  2020cited by this paper
• Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

  2020cited by this paper
• Novel biosensor for acetylcholine based on acetylcholinesterase/poly(neutral red) – Deep eutectic solvent/Fe2O3 nanoparticle modified electrode

  2020cited by this paper
• Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease.

  2020cited by this paper
• Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy

  2020cited by this paper
• LVFFARK-PEG-Stabilized Black Phosphorus Nanosheets Potently Inhibit Amyloid-β Fibrillogenesis.

  2020cited by this paper
• New Insights Into the Pathogenesis of Alzheimer's Disease

  2020cited by this paper
• Clinical trials of new drugs for Alzheimer disease

  2020cited by this paper
• Deciphering Alzheimer’s disease: predicting new therapeutic strategies via improved understanding of biology and pathogenesis

  2020cited by this paper
• Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s disease

  2020cited by this paper
• Fluorescent Dopamine-tryptophan nanocomposites as dual imaging and anti-aggregation agents: New generation of amyloid theranostics with trimeric effects.

  2020cited by this paper
• AmyloLipid Nanovesicles: A Self-Assembled Lipid-Modified Starch Hybrid System Constructed for Direct Nose-to-Brain Delivery of Curcumin.

  2020cited by this paper
• Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection

  2020cited by this paper
• Interfacial charge transfer with exfoliated graphene inhibits fibril formation in lysozyme amyloid.

  2020cited by this paper
• Beta‐Amyloid Oligomers: Amyloid‐β Oligomer‐Targeted Gadolinium‐Based NIR/MR Dual‐Modal Theranostic Nanoprobe for Alzheimer's Disease (Adv. Funct. Mater. 16/2020)

  2020cited by this paper
• Edinburgh Research Explorer Evaluation of neurological effects of cerium dioxide nanoparticles doped with different amounts of zirconium following inhalation exposure in mouse models of Alzheimer’s and vascular disease

  2020cited by this paper
• Ultrasmall superparamagnetic iron oxide nanoparticles-bound NIR dyes: Novel theranostic agents for Alzheimer's disease

  2020cited by this paper
• Bi-functional sterically hindered phenol lipid-based delivery systems as potential multi-target agents against Alzheimer's disease via an intranasal route.

  2020cited by this paper
• Graphene FET Sensors for Alzheimer’s Disease Protein Biomarker Clusterin Detection

  2020cited by this paper
• Comprehensive Review on Alzheimer’s Disease: Causes and Treatment

  2020cited by this paper
• Graphene oxide improves postoperative cognitive dysfunction by maximally alleviating amyloid beta burden in mice

  2020cited by this paper
• Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.

  2020cited by this paper
• Nitrogen-Doped Carbonized Polymer Dots: A Potent Scavenger and Detector Targeting Alzheimer's β-Amyloid Plaques.

  2020cited by this paper
• Neuroprotective Effect of Nerve Growth Factor Loaded in Porous Silicon Nanostructures in an Alzheimer's Disease Model and Potential Delivery to the Brain.

  2019cited by this paper
• Protein Capped Metal Nanoparticles Inhibits Tau Aggregation in Alzheimer’s Disease

  2019cited by this paper
• Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease

  2019cited by this paper
• A BODIPY biosensor to detect and drive self-assembly of diphenylalanine.

  2019cited by this paper
• A tyrosinase-induced fluorescence immunoassay for detection of tau protein using dopamine-functionalized CuInS2/ZnS quantum dots

  2019cited by this paper
• Development of Chemically Signal Amplified Nano-Biosensor Mediated by Poly-L-Lysine.

  2019cited by this paper
• SNAP-25 in Serum Is Carried by Exosomes of Neuronal Origin and Is a Potential Biomarker of Alzheimer’s Disease

  2019cited by this paper
• Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease.

  2019cited by this paper
• Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies

  2019cited by this paper
• Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain

  2019cited by this paper
• Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process

  2019cited by this paper
• Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release.

  2019cited by this paper
• Destabilization of amyloid fibrils on interaction with MoS2-based nanomaterials

  2019cited by this paper
• Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer's disease.

  2019cited by this paper
• Design, synthesis and evaluation of a novel metal chelator as multifunctional agents for the treatment of Alzheimer's disease.

  2019cited by this paper
• Carbon nanomaterials and amyloid‐beta interactions: potentials for the detection and treatment of Alzheimer's disease?

  2019cited by this paper
• In vivo neuronal gene editing via CRISPR–Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease

  2019cited by this paper
• The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine

  2019cited by this paper
• Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease.

  2019cited by this paper
• Therapeutic Effects of Natural Drugs on Alzheimer’s Disease

  2019cited by this paper
• Preparation and in vitro evaluation of multi-target-directed selenium-chondroitin sulfate nanoparticles in protecting against the Alzheimer's disease.

  2019cited by this paper
• Alzheimer’s Disease – Future Therapy Based on Dendrimers

  2019cited by this paper
• Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain.

  2019cited by this paper
• Improvement of Memory Deficits in the Rat Model of Alzheimer's Disease by Erythropoietin-Loaded Solid Lipid Nanoparticles.

  2019cited by this paper
• Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations

  2018cited by this paper
• Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease

  2018cited by this paper
• A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers

  2018cited by this paper
• A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer's Disease Treatment.

  2018cited by this paper
• Chitosan Glutamate-Coated Niosomes: A Proposal for Nose-to-Brain Delivery

  2018cited by this paper
• Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging.

  2018cited by this paper
• Systemic delivery of BACE1 siRNA through neuron‐targeted nanocomplexes for treatment of Alzheimer's disease

  2018cited by this paper
• Randomized Trial of Verubecestat for Mild‐to‐Moderate Alzheimer's Disease

  2018cited by this paper
• Inhibition of Al(III)-Induced Aβ42 Fibrillation and Reduction of Neurotoxicity by Epigallocatechin-3-Gallate Nanoparticles.

  2018cited by this paper
• Design and Efficacy of Nanogels Formulations for Intranasal Administration

  2018cited by this paper
• In vitro neuroprotective effects of naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation.

  2018cited by this paper
• Self-Assembled Curcumin-Poly(carboxybetaine methacrylate) Conjugates: Potent Nano-Inhibitors against Amyloid β-Protein Fibrillogenesis and Cytotoxicity.

  2018cited by this paper
• Heat Shock Proteins in Alzheimer’s Disease: Role and Targeting

  2018cited by this paper
• Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review

  2018cited by this paper
• Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

  2018cited by this paper
• PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies

  2018cited by this paper
• Alzheimer's amyloid-beta intermediates generated using polymer-nanodiscs.

  2018cited by this paper
• Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of β-Amyloid Aggregates in Alzheimer's Disease Mice.

  2018cited by this paper
• A DNA nanomachine chemically resolves lysosomes in live cells

  2018cited by this paper
• Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer’s disease

  2017cited by this paper
• Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer’s Disease

  2017cited by this paper
• Multimodal imaging Gd-nanoparticles functionalized with Pittsburgh compound B or a nanobody for amyloid plaques targeting.

  2017cited by this paper
• Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ1-42-induced neuroinflammation and neurodegeneration via the NF-KB /JNK/GSK3β signaling pathway.

  2017cited by this paper
• A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

  2017cited by this paper
• Amyloid beta: structure, biology and structure-based therapeutic development

  2017cited by this paper
• The worldwide costs of dementia 2015 and comparisons with 2010

  2017cited by this paper
• Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model.

  2017cited by this paper
• Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity

  2017cited by this paper
• PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice

  2017cited by this paper
• Recent Progress in Alzheimer’s Disease Research, Part 2: Genetics and Epidemiology

  2017cited by this paper
• Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery.

  2017cited by this paper
• A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles

  2017cited by this paper
• Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease

  2017cited by this paper
• Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.

  2016cited by this paper
• Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis

  2016cited by this paper
• Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer's disease treatment.

  2016cited by this paper
• Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

  2016cited by this paper
• Dye-Sensitized Core/Active Shell Upconversion Nanoparticles for Optogenetics and Bioimaging Applications.

  2016cited by this paper
• Correction to Direct Tracking of Amyloid and Tau Dynamics in Neuroblastoma Cells Using Nanoplasmonic Fiber Tip Probes.

  2016cited by this paper
• Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management

  2016cited by this paper
• Selenium compounds as therapeutic agents in cancer.

  2015cited by this paper
• Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease.

  2015cited by this paper
• Nanomedicine for the treatment of Alzheimer's disease.

  2015cited by this paper

• Frontiers in neurodegeneration: Biomolecular triggers, diagnostic biomarkers, and smart nanotherapeutics

  2026cites this paper
• Advances in Alzheimer's Therapy: Exploring Neuropathological Mechanisms to Revolutionize the Future Therapeutic Landscape.

  2025cites this paper
• Therapeutic and clinical potential of thiolutin microneedles on Alzheimer's disease mitigation.

  2025cites this paper
• Liposomal and Nanomaterial-Based Strategies for Targeted Alzheimer’s Disease Therapy

  2025cites this paper
• Development of sustained release injectable phospholipid-based phase transition gel matrixed with Piracetam and cannabidiol loaded nanoemulsion for amelioration of Alzheimer’s therapy

  2025cites this paper
• A study to determine the effect of nano-selenium and thymoquinone on the Nrf2 gene expression in Alzheimer’s disease

  2025cites this paper
• Liver-X receptor β-selective agonist CE9A215 regulates Alzheimer's disease-associated pathology in a 3xTg-AD mouse model.

  2025cites this paper
• In vitro and in silico anti-Alzheimer study of rutin embedded with zinc chloride loaded bovine serum albumin nanoparticles.

  2025cites this paper
• A comprehensive approach to Alzheimer's Disease: Exploring Nanotechnology, treatment Innovations, and sex differences.

  2025cites this paper
• Innovative strategies for overcoming blood-brain barrier challenges in Alzheimer’s disease: A focus on green-synthesized metallic nanoparticles

  2024cites this paper
• The Interplay of Protein Aggregation, Genetics, and Oxidative Stress in Alzheimer’s Disease: Role for Natural Antioxidants and Immunotherapeutics

  2024cites this paper
• Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management

  2023cites this paper